Literature DB >> 10601631

The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures.

F Flohr1, S Schneider-Schaulies, O Haller, G Kochs.   

Abstract

To define domains of the human MxA GTPase involved in GTP hydrolysis and antiviral activity, we used two monoclonal antibodies (mAb) directed against different regions of the molecule. mAb 2C12 recognizes an epitope in the central interactive region of MxA, whereas mAb M143 is directed against the N-terminal G domain. mAb 2C12 greatly stimulated MxA GTPase activity, suggesting that antibody-mediated crosslinking enhances GTP hydrolysis. In contrast, monovalent Fab fragments of 2C12 abolished GTPase activity, most likely by blocking intramolecular interactions required for GTPase activation. Interestingly, intact IgG molecules and Fab fragments of 2C12 both prevented association of MxA with viral nucleocapsids and neutralized MxA antiviral activity in vivo. mAb M143 had no effect on MxA function, indicating that this antibody binds outside functional regions. These data demonstrate that the central region recognized by 2C12 is critical for regulation of GTPase activity and viral target recognition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601631     DOI: 10.1016/s0014-5793(99)01598-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  60 in total

1.  A monomeric GTPase-negative MxA mutant with antiviral activity.

Authors:  C Janzen; G Kochs; O Haller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Mx is dispensable for interferon-mediated resistance of chicken cells against influenza A virus.

Authors:  Benjamin Schusser; Antje Reuter; Alexander von der Malsburg; Nicola Penski; Steffen Weigend; Bernd Kaspers; Peter Staeheli; Sonja Härtle
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains.

Authors:  Sina Kirsanovs; Boris Klempa; Renate Franke; Min-Hi Lee; Günther Schönrich; Andreas Rang; Detlev H Kruger
Journal:  Virus Genes       Date:  2010-08-24       Impact factor: 2.332

Review 4.  Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity.

Authors:  Otto Haller; Song Gao; Alexander von der Malsburg; Oliver Daumke; Georg Kochs
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

5.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Positive diversifying selection in avian Mx genes.

Authors:  Sofia Berlin; Lujiang Qu; Xianyao Li; Ning Yang; Hans Ellegren
Journal:  Immunogenetics       Date:  2008-08-26       Impact factor: 2.846

Review 7.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

8.  Pregnancy-associated genes contribute to antiluteolytic mechanisms in ovine corpus luteum.

Authors:  Jared J Romero; Alfredo Q Antoniazzi; Natalia P Smirnova; Brett T Webb; Fang Yu; John S Davis; Thomas R Hansen
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

9.  Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Authors:  Mirjam Schilling; Lorenzo Bulli; Sebastian Weigang; Laura Graf; Sebastian Naumann; Corinna Patzina; Valentina Wagner; Liane Bauersfeld; Caroline Goujon; Hartmut Hengel; Anne Halenius; Zsolt Ruzsics; Torsten Schaller; Georg Kochs
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

10.  Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein.

Authors:  Judith Verhelst; Dorien De Vlieger; Xavier Saelens
Journal:  J Vis Exp       Date:  2015-04-21       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.